MENU
MAZE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Maze Therapeutics (MAZE) Ownership - Who owns Maze Therapeutics?

Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small-molecule precision medicines for patients living with renal, cardiovascular, and related metabolic, or CVRM, diseases, including obesity... Show more

Profile

Industry
N/A
Address
171 Oyster Point boulevard
Phone
+1 650 850-5070
Employees
141
Web
https://www.mazetx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.49B
P/E Ratio
191.34
Total Cash
411.09M
Projected Growth
N/A
Total Debt
60.42M
Revenue
20M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
7.40
Total Debt/Equity
N/A
Revenue/Share
0.38 USD as % of share price
Who owns Maze Therapeutics? MAZE symbol Ownership - Tickeron.com